Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Monolith Management is a tech-focused hedge fund and investment manager based in Asia, primarily investing in technology growth companies across public and private markets. It has demonstrated strong performance, notably achieving 53% growth driven by semiconductor investments and strategic positioning in Asian markets. The firm manages at least one closed fund as of June 2023 and plans to expand assets under management from $300 million to $500 million with new funds launching in 2024.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Monolith Management.